February 3, 2023 Comments Off on New patent for Galderma Labs drug EPSOLAY Posted in: Patent Added Annual Drug Patent Expirations for EPSOLAY Epsolay is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Galderma Labs drug EPSOLAY appeared first on DrugPatentWatc…
January 31, 2023 Comments Off on New patent for Abbvie Inc drug RINVOQ Posted in: Patent Added Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are sixteen patents…
The post New patent for Abbvie Inc drug RINVOQ appeared first on DrugPatentWatch…